SCHEMBL5925628

SCHEMBL5925628

CCCC(=O)Nc1ccc(N)c(Cl)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.68
▸ HPGD P15428 3/20 0.68
▸ MEN1 O00255 1/20 0.68
▸ LMNA P02545 1/20 0.68
▸ KMT2A Q03164 1/20 0.68
▸ TP53 P04637 1/20 0.56
▸ ESRRA P11474 1/20 0.55
▸ CYP2D6 P10635 1/20 0.55
▸ CYP2C9 P11712 1/20 0.55
▸ CYP3A4 P08684 1/20 0.55
▸ F2R P25116 2/20 0.53
▸ TSHR P16473 1/20 0.51
▸ CA12 O43570 1/20 0.51
▸ CA1 P00915 1/20 0.51
▸ CA2 P00918 1/20 0.51
▸ CA9 Q16790 1/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ PTPRC P08575 2/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ NPC1 O15118 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7641553 0.88 NPC1 (0.58) ALDH1A1HPGDMEN1LMNAKMT2A
SCHEMBL11308861 0.87 CYP3A4 (0.73) ALDH1A1HPGDMEN1LMNAKMT2A
SCHEMBL3674141 0.85 CYP3A4 (0.75) ALDH1A1HPGDMEN1LMNAKMT2A
SCHEMBL14886138 0.83 ALDH1A1 (0.70) ALDH1A1HPGDMEN1LMNAKMT2A
SCHEMBL11693512 0.83 ALDH1A1 (0.65) ALDH1A1HPGDMEN1LMNAKMT2A
SCHEMBL21698047 0.82 CYP3A4 (0.51) ALDH1A1HPGDMEN1LMNAKMT2A
SCHEMBL9137517 0.82 GSTO1 (0.52) ALDH1A1LMNACYP3A4TSHRNPC1
SCHEMBL7111208 0.82 ALDH1A1 (0.63) ALDH1A1HPGDMEN1LMNAKMT2A
SCHEMBL7923953 0.81 MAPT (0.54) ALDH1A1MEN1KMT2ACYP3A4TSHR
SCHEMBL11640106 0.81 CYP3A4 (0.50) ALDH1A1HPGDMEN1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060110743-A1 Drug evolution: drug design at hot spots KONISHI YASUO 2006-05-25 — — US disclosed
WO-2002095393-A2 DRUG EVOLUTION: DRUG DESIGN AT HOT SPOTS NATIONAL RESEARCH COUNCIL OF CANADA (CA) 2002-11-28 — — WO disclosed
Send feedback